PYXSPyxis Oncology, Inc.

Nasdaq pyxisoncology.com


$ 4.39 $ -0.03 (-0.68 %)    

Friday, 03-May-2024 15:59:50 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 4.38
$ 4.46
$ 4.38 x 400
$ 0.00 x 0
$ 4.29 - $ 4.76
$ 1.35 - $ 6.85
818,440
na
154.84M
$ 1.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-22-2023 12-31-2022 10-K
6 11-01-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-29-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-pyxis-oncology-maintains-7-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Pyxis Oncology (NASDAQ:PYXS) with a Buy and maintains $7 p...

 why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

 signet-jewelers-dave--busters-entertainment-blue-owl-capital-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.

 rbc-capital-reiterates-outperform-on-pyxis-oncology-maintains-7-price-target

RBC Capital analyst Leonid Timashev reiterates Pyxis Oncology (NASDAQ:PYXS) with a Outperform and maintains $7 price target.

 why-fedex-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket

Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expe...

 hc-wainwright--co-maintains-buy-on-pyxis-oncology-raises-price-target-to-7

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Pyxis Oncology (NASDAQ:PYXS) with a Buy and raises the pric...

 why-factset-research-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-th...

 pyxis-oncology-fy-eps-185-beats-195-estimate-cash-and-cash-equivalents-of-1208m-and-gross-procced-of-108m-and-50m-via-atm-offering-and-private-placement-is-expected-to-provide-cash-runway-into-2h-2026

Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(1.85) per share which beat the analyst consensus estimate of $(1.95...

 pyxis-oncology-to-present-new-pyx-201-pyx-106-and-pyx-102-preclinical-data-at-aacr-annual-meeting

PYX-201, an EDB+FN-specific tumor stroma-targeting ADC, demonstrates potent anti-tumor efficacy across multiple human cancers i...

 why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

 btig-initiates-coverage-on-pyxis-oncology-with-buy-rating-announces-price-target-of-8

BTIG analyst Kaveri Pohlman initiates coverage on Pyxis Oncology (NASDAQ:PYXS) with a Buy rating and announces Price Target ...

 leerink-partners-initiates-coverage-on-pyxis-oncology-with-outperform-rating-announces-price-target-of-12

Leerink Partners analyst Jeffrey La Rosa initiates coverage on Pyxis Oncology (NASDAQ:PYXS) with a Outperform rating and ann...

 hc-wainwright--co-initiates-coverage-on-pyxis-oncology-with-buy-rating-announces-price-target-of-4

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Pyxis Oncology (NASDAQ:PYXS) with a Buy rating ...

 pyxis-oncology-q3-eps-056-misses-051-estimate

Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION